Kenvue stock holds near $19 after a $3.96 billion quarter
Published on 08/31/2026 at 09:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Kenvue Inc. (US49177J1025) reported $3.96 billion in quarterly revenue and $0.31 in earnings per share for the June quarter, while the shares recently opened at $19.15 and the market cap stood at $36.78 billion.
June quarter stays the reference point
The same update says revenue rose 3.0% from a year earlier, while EPS missed consensus by $0.01 after the company posted $0.29 per share in the same quarter last year. Net margin was 10.76%, a useful anchor for a consumer staples name whose earnings quality now matters as much as volume growth.
Sell-side analysts now have Kenvue at 1.14 EPS for the current fiscal year, which gives investors a clean comparison point against the $0.31 quarterly print and the recent $19.27 consensus price target cited in the same market update.
Valuation and earnings power
The stock's P/E ratio was 22.01 in the latest market snapshot, and the beta of 0.47 points to a calmer profile than the broad market. That mix leaves the June quarter's 3.0% year-over-year revenue growth more important than short-term sentiment swings.
For investors, the number to watch is whether Kenvue can turn a $3.96 billion quarter into a cleaner earnings trend after the $0.01 EPS miss and the narrow gap to the consensus target.
Tylenol remains the flagship
Tylenol is one of Kenvue's best-known brands and remains central to the company's consumer health portfolio, alongside other OTC and personal care products. The brand mix matters because the company is judged less like a pure growth name and more like a steady cash-generating staples business.
Shares and market setup
Kenvue stock traded at $19.15 in the latest market snapshot, with the market cap at $36.78 billion and the P/E ratio at 22.01. The combination of a 3.0% revenue rise, a $0.31 EPS print, and a 10.76% net margin keeps the shares anchored to execution rather than narrative.
More on Kenvue stock
More on Kenvue stock and its consumer health portfolio.
Company
Company: Kenvue Inc.
ISIN: US49177J1025
Ticker: KVUE
Exchange: NYSE
Sector / Industry: Consumer Staples / Household & Personal Products
Index membership: S&P 500
